Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study will examine the safety and effectiveness of a combination kidney and bone marrow
transplant from a relative with the same (or nearly the same) blood cell type as the
transplant recipient. An investigational medication will be given prior to and after the
transplant to help protect the transplanted kidney from attack by the body's immune system.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)